Back to results
US 2008/0188458 A1Published application
Compounds for the Treatment of Hepatitis C
AssigneeBristol-Myers Squibb Company
InventorsKap-Sun Yeung, John F. Kadow, Katharine A. Grant-Young
Life of this patent
Estimating the term…
Abstract
The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
Claims18
A compound of formula I
- where:
- R1 is CO2R6 or CONR7R8;
- R2 is COR2, COCOR, SO2N(R14)(R15), or SO2R16;
- R3 is hydrogen or alkyl;
- R4 is hydrogen, halo, alkyl, alkenyl, hydroxy, benzyloxy, or alkoxy;
- R5 is cycloalkyl;
- R6 is hydrogen or alkyl;
- R7 is hydrogen, alkyl, alkylSO2, cycloalkylSO2, haloalkylSO2, (R9)2NSO2, or (R10)SO2;
- R8 is hydrogen or alkyl;
- R9 is hydrogen or alkyl;
- R10 is azetidinyl, pyrrolidinyl, piperidinyl, N—(R11)piperazinyl, morpholinyl, thiomorpholinyl, homopiperidinyl, N—(R11)homopiperazinyl, or homomorpholinyl;
- R11 is hydrogen or alkyl;
- and
- R12 is amino, alkylamino, or dialkylamino;
- or R12 is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, morpholinyl, homopiperidinyl, homopiperazinyl, or homomorpholinyl, and is substituted with 0-3 substituents selected from alkyl, alkoxy, and phenyl wherein phenyl is substituted with 0-3 substituents selected from cyano, halo, alkyl, and alkoxy;
- or R12 is
- R13 is hydroxy, alkoxy, amino, alkylamino, or dialkylamino;
- or R13 is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, morpholinyl, homopiperidinyl, homopiperazinyl, or homomorpholinyl, and is substituted with 0-3 substituents selected from alkyl, alkoxy, and phenyl wherein phenyl is substituted with 0-3 substituents selected from cyano, halo, alkyl, and alkoxy;
- or R13 is
- R14 is hydrogen, or alkyl;
- R15 is hydrogen or alkyl;
- R16 is alkyl, cycloalkyl, or haloalkyl;
- or R16 is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, homopiperidinyl, homopiperazinyl, or homomorpholinyl, and is substituted with 0-3 substituents selected from alkyl, alkylcarbonyl, alkoxycarbonyl, benzyl, and benzyloxycarbonyl;
- or R16 is phenyl substituted with 0-3 substituents selected from cyano, halo, alkyl, haloalkyl, alkoxy, and haloalkoxy;
- R17 is hydrogen, alkyl, cycloalkyl, (cycloalkyl)alkyl, benzyl, alkylcarbonyl, alkoxycarbonyl, benzyloxycarbonyl, alkylSO2, or pyridinyl;
- and
- X is absent, a bond, or methylene;
- or a pharmaceutically acceptable salt thereof.
25 more elements
Dependencies are inferred from the claim text.